Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.32 USD | +0.34% | -15.17% | -40.46% |
Jun. 03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.46% | 3.68B | |
+49.73% | 55.7B | |
+39.38% | 39.91B | |
-6.64% | 39.57B | |
-6.65% | 28.16B | |
+13.65% | 26.3B | |
-21.62% | 18.94B | |
+29.86% | 12.17B | |
+25.80% | 12.12B | |
+0.08% | 12.12B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Oppenheimer Initiates Coverage on Immunovant With Outperform Rating, $50 Price Target